Scarica l'app Stockscreener
0.00
100.00%
-79.97
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché NARI Giù?
Forum
Previsione
Precedente Chiudi:
$79.97
Aprire:
$0
Volume 24 ore:
0
Relative Volume:
0.00
Capitalizzazione di mercato:
$4.68B
Reddito:
$574.50M
Utile/perdita netta:
$-78.58M
Rapporto P/E:
0.00
EPS:
-1.35
Flusso di cassa netto:
$1.58M
1 W Prestazione:
-100.00%
1M Prestazione:
-100.00%
6M Prestazione:
-100.00%
1 anno Prestazione:
-100.00%
Intervallo 1D:
$0.00
$0.00
Intervallo di 1 settimana:
$0.00
$0.00
Portata 52W:
$0.00
$79.99
Inari Medical Inc Stock (NARI) Company Profile
Nome
Inari Medical Inc
Settore
Industria
Telefono
949-923-4747
Indirizzo
6001 OAK CANYON, SUITE 100, IRVINE, CA
Confronta NARI con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
NARI
Inari Medical Inc
|
0.00 | 4.68B | 574.50M | -78.58M | 1.58M | -1.35 |
|
ABT
Abbott Laboratories
|
128.85 | 225.27B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
101.90 | 138.41B | 17.55B | 2.03B | 2.37B | 1.37 |
|
SYK
Stryker Corp
|
365.06 | 129.62B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
84.16 | 107.92B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
76.04 | 40.53B | 5.54B | 4.18B | 259.90M | 7.00 |
Inari Medical Inc Stock (NARI) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-12-17 | Iniziato | Oppenheimer | Outperform |
| 2024-09-18 | Iniziato | Stifel | Hold |
| 2024-09-03 | Iniziato | Leerink Partners | Market Perform |
| 2024-08-09 | Iniziato | Deutsche Bank | Buy |
| 2024-07-25 | Iniziato | William Blair | Outperform |
| 2024-07-18 | Downgrade | Needham | Buy → Hold |
| 2024-02-29 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2024-01-23 | Iniziato | Needham | Buy |
| 2023-07-19 | Iniziato | Robert W. Baird | Outperform |
| 2022-10-12 | Iniziato | Jefferies | Buy |
| 2022-09-29 | Iniziato | Berenberg | Buy |
| 2022-09-13 | Iniziato | Truist | Hold |
| 2022-06-21 | Iniziato | Piper Sandler | Overweight |
| 2022-03-23 | Ripresa | BofA Securities | Buy |
| 2020-12-15 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2020-11-18 | Iniziato | BTIG Research | Buy |
| 2020-10-29 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2020-09-28 | Iniziato | SVB Leerink | Outperform |
| 2020-06-19 | Iniziato | Canaccord Genuity | Buy |
| 2020-06-16 | Iniziato | BofA/Merrill | Neutral |
| 2020-06-16 | Iniziato | Morgan Stanley | Equal-Weight |
| 2020-06-16 | Iniziato | Wells Fargo | Equal Weight |
Mostra tutto
Inari Medical Inc Borsa (NARI) Ultime notizie
Press Release Distribution & PR Platform - ACCESS Newswire
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Inari Medical, Inc.(NARI) Shareholders - ACCESS Newswire
NARI LAWSUIT ALERT: Levi & Korsinsky Notifies Inari Medical, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - ACCESS Newswire
Inari Medical stock soars to 52-week high of $79.95 - MSN
Paul Mullen Chosen to Lead Microbot Medical’s U.S. Sales Force - Medical Product Outsourcing
Imperative Care Expands Precision Thrombectomy Portfolio - Diagnostic and Interventional Cardiology
Inari Medical, Inc. INVESTIGATION: Levi & Korsinsky Investigates Potential Securities Fraud by Inari Medical, Inc. (NARI) - ACCESS Newswire
NARI SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLCRECOGNIZED INVESTOR COUNSELReminds Inari Medical, Inc. Shareholders to Lead Class Action Lawsuit! - ACCESS Newswire
Inari Medical introduces thrombectomy system for arterial thrombus cases - Yahoo Finance
Inari Medical, now part of Stryker, launches Artix™ Thrombectomy System, designed to address a broad spectrum of arterial thrombus cases - PR Newswire
NARI STOCK ALERT: Levi & Korsinsky Notifies Inari Medical, Inc. Investors of an Ongoing Investigation - ACCESS Newswire
Microbot Medical Appoints Seasoned Endovascular Sales - GlobeNewswire
Microbot Medical Appoints Seasoned Endovascular Sales Executive to Lead its U.S. Sales Activities for LIBERTY® Endovascular Robotic System - The Manila Times
Can This Executive From a $4.94B Acquired Company Drive Microbot's Robotic System to Market Success? - StockTitan
Inari Medical, Inc. Class Action: Levi & Korsinsky Reminds Inari Medical Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of July 12, 2024NARI - accessnewswire.com
INARI MEDICAL SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Inari Medical, I - ACCESS Newswire
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Inari Medical, Inc. (NARI) Shareholders - ACCESS Newswire
Lost Money on Inari Medical, Inc.(NARI)? Join Class Action Suit Seeking Recovery – Contact Levi & Korsinsky - ACCESS Newswire
Shareholders that lost money on Inari Medical, Inc.(NARI) Urged to Join Class ActionContact Levi & Korsinsky to Learn More - ACCESS Newswire
Is Inari Medical, Inc. (NARI) the Hottest Smid-Cap Stock So Far In 2025? - MSN
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Inari Medical, Inc. (NARI) And Encourages Shareholders to Reach Out - ACCESS Newswire
Lost Money on Inari Medical, Inc.(NARI)? Contact Levi & Korsinsky Regarding an Ongoing Investigation - ACCESS Newswire
Shareholder Rights Advocates at Levi & Korsinsky Investigate Inari Medical, Inc. (NARI) Regarding Possible Securities Fraud Violations - accessnewswire.com
NARI ACTIVE INVESTIGATION: Contact Levi & Korsinsky if you lost money on your Inari Medical, Inc. investment - ACCESS Newswire
Inari Medical Inc to Host Earnings Call - ACCESS Newswire
An Investigation Has Commenced on Behalf of Inari Medical, Inc. Shareholders. Contact Levi & Korsinsky to Discuss your NARI Losses. - ACCESS Newswire
Inari Medical, Inc. Sued for Securities Law ViolationsContact Levi & Korsinsky Before July 12, 2024 to Discuss Your RightsNARI - ACCESS Newswire
Inari Medical, Inc. (NARI) Investors with Losses are Urged to Contact Levi & Korsinsky to Discuss Their Rights - ACCESS Newswire
Inari Medical, Figs Inc, Fastly, and Ryvyl Investigation - GlobeNewswire
Inari Medical, Figs Inc, Fastly, and Ryvyl Investigation Alert: Johnson Fistel, LLP Encourages Long-Term - EIN News
Stryker grows cardiovascular division with Inari Medical acquisition - Yahoo Finance
Levi & Korsinsky Reminds Inari Medical, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of July 12, 2024NARI - ACCESS Newswire
Levi & Korsinsky Notifies Inari Medical, Inc. Investors of a Class Action Lawsuit and Upcoming DeadlineNARI - ACCESS Newswire
Stryker Completes Acquisition of Inari Medical Inc. for $4.94 BillionOn February 19, 2025, Stryker Corporation finalized the acquisition of Inari Medical, Inc., marking a significant strategic move for the company. The acquisition was completed in al - Defense World
Inari Medical, Inc. Investigated by Shareholder Rights AdvocatesInvestors Should Contact Levi & Korsinsky Regarding Potential Securities Law ViolationsNARI - ACCESS Newswire
Lost Money on Inari Medical, Inc.(NARI)? Join Class Action Suit Seeking RecoveryContact Levi & Korsinsky - ACCESS Newswire
Stryker Completes $4.9 Billion Acquisition of Inari - Orange County Business Journal
Stryker completes $4.94 billion Inari Medical acquisition By Investing.com - Investing.com South Africa
Stryker concludes Inari Medical acquisition for $4.9bn - Yahoo Finance
Stryker Corporation (SYK) Completes Acquisition of Inari Medical - GuruFocus.com
Inari Medical, Inc. (NARI): the Best Performing Healthcare Stock So Far in 2025 - Insider Monkey
10 Best Performing Healthcare Stocks So Far in 2025 - Insider Monkey
Stryker Completes Acquisition Of Inari Medical -February 19, 2025 at 10:19 am EST - Marketscreener.com
Inari Medical Inc Azioni (NARI) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.01%
0.60%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):